Home > Financial Ratios > CONCORD DRUGS

CONCORD DRUGS
Cash Earnings per Share (CEPS)

    Back to All Ratios
CONCORD DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   CEPS(Rs) 1.772.032.803.84

What is the latest Cash Earnings per Share (CEPS) ratio of CONCORD DRUGS ?

The latest Cash Earnings per Share (CEPS) ratio of CONCORD DRUGS is 1.77 based on Mar2025 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar20251.77
Mar20242.03
Mar20232.80
Mar20223.84

How is Cash Earnings per Share (CEPS) of CONCORD DRUGS Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2025 1.77
-12.81
Mar2024 2.03
-27.50
Mar2023 2.8
-27.08
Mar2022 3.84 -

Other Financial Ratios of CONCORD DRUGS


Compare Cash Earnings per Share (CEPS) ratio of peers of CONCORD DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD DRUGS ₹99.4 Cr -5.5% 5.2% 12.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹110,794.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 0.9% 0% -11% Stock Analytics


CONCORD DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD DRUGS

-5.5%

5.2%

12.3%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses